CN104845881A - Apparatus and method for producing anti-CD52 monoclonal antibodies through online industrially robust regulation of cell states - Google Patents
Apparatus and method for producing anti-CD52 monoclonal antibodies through online industrially robust regulation of cell states Download PDFInfo
- Publication number
- CN104845881A CN104845881A CN201410052560.1A CN201410052560A CN104845881A CN 104845881 A CN104845881 A CN 104845881A CN 201410052560 A CN201410052560 A CN 201410052560A CN 104845881 A CN104845881 A CN 104845881A
- Authority
- CN
- China
- Prior art keywords
- cell
- control
- regulation
- bioreactor
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012544 monitoring process Methods 0.000 claims abstract description 106
- 238000000034 method Methods 0.000 claims abstract description 97
- 229940124296 CD52 monoclonal antibody Drugs 0.000 claims abstract description 75
- 238000004113 cell culture Methods 0.000 claims abstract description 54
- 230000010261 cell growth Effects 0.000 claims abstract description 44
- 230000022131 cell cycle Effects 0.000 claims abstract description 29
- 230000014759 maintenance of location Effects 0.000 claims description 60
- 230000033228 biological regulation Effects 0.000 claims description 58
- 239000012530 fluid Substances 0.000 claims description 54
- 230000008569 process Effects 0.000 claims description 46
- 230000036512 infertility Effects 0.000 claims description 41
- 235000015097 nutrients Nutrition 0.000 claims description 38
- 230000014509 gene expression Effects 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 19
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 230000001413 cellular effect Effects 0.000 claims description 16
- 238000012258 culturing Methods 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 239000002699 waste material Substances 0.000 claims description 15
- 230000010412 perfusion Effects 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 230000018199 S phase Effects 0.000 claims description 13
- 230000003833 cell viability Effects 0.000 claims description 13
- 239000007789 gas Substances 0.000 claims description 13
- 230000004668 G2/M phase Effects 0.000 claims description 12
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 12
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 12
- 239000003150 biochemical marker Substances 0.000 claims description 12
- 230000006870 function Effects 0.000 claims description 12
- 238000003306 harvesting Methods 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 11
- 235000014655 lactic acid Nutrition 0.000 claims description 11
- 238000005204 segregation Methods 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 239000006285 cell suspension Substances 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 230000010190 G1 phase Effects 0.000 claims description 9
- 238000009826 distribution Methods 0.000 claims description 9
- 230000035519 G0 Phase Effects 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 8
- 230000002572 peristaltic effect Effects 0.000 claims description 7
- 239000000523 sample Substances 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 235000011089 carbon dioxide Nutrition 0.000 claims description 6
- 238000002203 pretreatment Methods 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 5
- 239000012679 serum free medium Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 230000019522 cellular metabolic process Effects 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- -1 cell density Chemical compound 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000012531 culture fluid Substances 0.000 claims description 3
- 235000001727 glucose Nutrition 0.000 claims description 3
- 229960002989 glutamic acid Drugs 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 230000036284 oxygen consumption Effects 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 230000029305 taxis Effects 0.000 claims description 3
- 230000014616 translation Effects 0.000 claims description 3
- 230000005540 biological transmission Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 230000006386 memory function Effects 0.000 claims description 2
- 230000003204 osmotic effect Effects 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 230000001276 controlling effect Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000016784 immunoglobulin production Effects 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 289
- 229940112129 campath Drugs 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000006228 supernatant Substances 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 102000013135 CD52 Antigen Human genes 0.000 description 7
- 108010065524 CD52 Antigen Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012737 fresh medium Substances 0.000 description 4
- 238000011169 microbiological contamination Methods 0.000 description 4
- 201000006417 multiple sclerosis Diseases 0.000 description 4
- 230000003946 protein process Effects 0.000 description 4
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 3
- 241000699802 Cricetulus griseus Species 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000012365 batch cultivation Methods 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 238000003973 irrigation Methods 0.000 description 3
- 230000002262 irrigation Effects 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 241000594182 Sarcophaga sigma Species 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000018486 cell cycle phase Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000012637 gene transfection Methods 0.000 description 2
- 230000009851 immunogenic response Effects 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 238000011165 process development Methods 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 241000005139 Lycium andersonii Species 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 1
- 108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000033581 fucosylation Effects 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention discloses a bioreactor cell culture apparatus capable of onlinely and continuously monitoring physiological and biochemical indexes in a variety of cell culture environments and directly regulating and controlling cell states (including cell cycle and the like), and a method for producing anti-CD52 monoclonal antibodies through the apparatus. With the apparatus and the method of the present invention, the bacterial pollution risk during the cell culture process can be reduced, the stable cell growth environment can be maintained, the constant cell growth viability can be maintained, and the high-quality, high-efficiency and continuous anti-CD52 monoclonal antibody production can be achieved.
Description
Technical field
The present invention relates in a kind of bioengineering field can on-line control and control the apparatus and method that cell state produces anti-CD52 monoclonal antibody, particularly relating to one can every reason biochemical indicator in the cell culture environment of on-line industry Robustness (industrially robust) monitoring continuously, continous pouring bio-reactor and culturing bottle/bag system, and can the cell cultures of direct-on-line regulation and control cell state, amplification and the anti-CD52 monoclonal antibody of preparation apparatus and method.
Background technology
Anti-CD52 monoclonal antibody, trade(brand)name Campath is the humanized monoclonal antibody of anti-CD52 of the expressing cho cell of recombinant DNA transfection, has the IgG1kappa antibody of the complementarity-determining region (CDR) in people antibody framework and constant region and mouse source.Antibody construction is the IgG1 heavy chain and the variable region of light chain that the heavy chain of antihuman CD 52 mouse resource monoclonal antibody (rat YTH 34.5HL, Campath-1G) and the CDR of light chain are inserted into respectively people, replaces the CDR of human antibody.Subsequently through antigen avidity and complement dependent cellular poison (CDC) screening active ingredients, by upper frame district, variable region of heavy chain 1(FR1) Ser27 sport Phe, Ser30 and sport Thr, thus obtain the high humanized antibody variable region fragment of antigen avidity.Above-mentioned variable region of heavy chain fragment is connected with the constant segments of human IgG1, variable region of light chain fragment is connected with human kappa light chain constant region, be built into the table carrier of heavy chain and light chain, cotransfection host cell, set up and express Campath(anti-CD52 monoclonal antibody) engineering cell strain, cell expressing and obtain albumen.The basic boom that IgG1 hypotype is selected as building Campath is better than other IgG hypotype based on it to have more effectively directed activation ADCC and CDC, has the high reactivity killing and wounding target cell.Campath maintains mouse source Campath-1G antibodies bind antigen feature, and the minimizing of mouse component is expected the people's immunogenic response reducing mouse source antibody and cause, but still has some patients can produce immunogenic response after repeat administration.
Campath is made up of 1328 amino acid, and molecular weight is about 150KD, containing two heavy chain molecules and two light chain molecule.Wherein light chain is made up of 214 amino acid, and molecular weight is about 24KDa; Heavy chain is made up of 450 amino acid, and molecular weight is about 49KDa.Have 12 disulfide linkage with interchain in chain, form typical Y type IgG1 molecule.Each heavy chain 301 has one can form the amino-succinamic acid residue of N-glycosyl and have sugar chain modified, mainly with the two branching type sugar chain structures that the oligonucleotide chain of fucosylation is core, containing 1 or not containing galactose residue.
The anti-CD52 monoclonal antibody of Campath() biological action is specific recognition cell surface CD52 antigen.CD52 antigen also claims Campath-1 antigen in early days.In lymphocyte differentiation process, lymphocyte obtains cell surface expression CD52 antigen, and about 5x10 can be expressed in individual cells surface
5cD52 molecule, forms the good target spot of antibody attack lymphocyte.CD52 is made up of 12 amino-acid residues, and Asn-3 is that N-connects glycosylation site, and antigen and cytolemma binding site are C-end Ser-12, connect cytolemma by glycolipid key.Antigen component inconsistent (glycosylation) its molecular weight 21-28kD of purifying, after N-Glycanase or Pronase process, decrease in molecular weight is to 6kD.CD52 antigen molecule is very little, and has glycolipid, and antigenic determinant is near cytolemma, and these structures shape CD52 antigens are good drug targets.
The glycosyl of Campath may be determine the determinative one of of antibody with or without anti-tumor activity, relevant with Fc regional function.The Fab fragment of deglycosylated Campath or Campath cannot replace Campath effect, shows that Campath Fab region and Fc region are all that Campath function is required.
At present, Campath is produced by Genzyme company in the U.S., is then located at factory and the production of German Bajer Schering Medicine Co., Ltd of UK & Ireland in Europe by Genzyme company.
In Chinese patent CN201210086437.2 " treating multiple sclerosis (MS) with CAMPATH-1H ", inventors describe the method for the treatment of multiple sclerosis (MS) with Campath-1H, described method has obvious effect and useful security, provide acceptable benefit/risk ratio, but this patent does not mention detailed antibody preparation technology and method.
With regard to the commercial processes of anti-CD52 monoclonal antibody, modem animal bioreactor culture expression technology is the key core technology of the said products, and this technical matters is complicated, difficulty is large.At present, the production expression method of anti-CD52 monoclonal antibody is generally and adopts batch cultivation, Fed batch fementation etc.Although these recombinant protein production technique are amplified to more than 1000L, there is following shortcoming in technique itself:
1) cultivate, it is less to express the state modulator of process, can not completely or can only the physico chemical factor of control culture environment of partial extent as temperature, pH, CO
2and O
2concentration, nutrient concentrations etc.;
2) even if accurately controlled reason biochemical condition by reactor, but this control method still lacks fine adjustment to cell state itself and control.The cell state be in growth and protein process greatly can affect final recombinant proteins of expressing (as the level of glycosylation of protein, the correct formation of protein secondary, tertiary structure), and cell state is not merely can be determined the impact of cell by parameters such as above-mentioned reason biochemistry, for the albumen that anti-CD52 monoclonal antibody is such, the protein-active that production obtains is that the protein mass far away than simple is important more;
3) repeatability of the cell of batch cultivation acquisition is lower, and be greatly subject to the impact of different experiments and production technology personnel individual operation, there will be difference (batch to batch variation) between larger batch in test with in producing, this is also one of difficult problem of current medicine quality control and supervision area.Therefore, a kind of Robustness (robust) with easy reliability large-scale (scalable) can be applied to the bottleneck that the production equipment of the anti-CD52 monoclonal antibody of industrialization (industrial) and technique are current expression process (process development) research fields.
In addition, describing cell for traditional technology cell state " good " and " bad " is a kind of colloquial expression, and " lag period ", " logarithmic phase " and " plateau " etc. speech be also a comparatively general concept, not accurately and accurate.According to open report, the state of Growth of Cells and the cell cycle distribution of whole colony have certain dependency.The behavior of the significant difference shown in fission process according to cell, the cell cycle can be roughly divided into three phases, see Fig. 1:
Gap 1 phase(G1 phase, G1 phase) be the initial period of a cell cycle, in this stage, cell interior carries out the behaviors such as the synthesis of related protein, and cell volume and genome do not produce any change;
Subsequently, cell can judge whether across restriction point (restriction point) by the environment residing for self, enter DNA synthesis phase (DNA synthesis phase, S phase, the S phase), in the S phase, the synthesis that cell mainly carries out autogene group DNA copies, after copying, cell becomes 2 times of bodies, and namely genome is double;
Cell enters m period (gap 2/mitotic phase, G2/M phase, G2/M phase) subsequently, and the phase at this moment, cell completes mitotic division, obtains two identical daughter cells, completes a cell cycle;
Environment is not good residing for the cell, and when being unfavorable for Growth of Cells, cell cannot stride across restriction point, thus jumps out the cell cycle, enters an extra quiet period (resting phase, G0 phase), becomes not somatoblast.
According to the cell behavior of cell at above-mentioned different cycles, detect nuclear DNA content by nuclei dyeing color reagent, coordinate flow cytometer and the cell cycle residing for distinguishable individual cells and draw the cell cycle distribution figure of whole colony.
For the cell in normal culturing process, cells intact is an asynchronous culture system (asynchronous culture), namely in culturing process, cells intact is not in the same position of cell cycle, but is randomly dispersed in each position of cell cycle.The characteristic shown in protein process due to the cell being in cell cycle different times may not be identical, the possibility of result that therefore cells intact presents be in fact by being in the different cell cycle, the cell cycle distribution of dynamic change-namely of proportion of cell of different states causes.
Summary of the invention
Because cell growth state itself greatly affects final recombinant proteins of expressing, and traditional cell cultures and protein expression are as batch cultivated and lack for the control of cell state is relative in feed-batch culture technique, while cell state be not merely can be determined the impact of cell by above-mentioned physical and chemical parameter.Therefore; realize cell growth state (i.e. Growth of Cells; the design parameters such as cell cycle distribution) accurate control, be set up the Robustness (robust) with easy reliability large-scale (scalable) important process of industrialization (industrial) anti-CD52 monoclonal antibody expression process (process development) to be applied to.
The object of the invention is to, for the above-mentioned shortcoming in current CD52 monoclonal antibody conventional preparation techniques, there is provided one both can online, continuously, multiple reason biochemical indicator in monitoring cell culture environment, again can directly regulation and control cell state (comprising the cell cycle etc.) bio-reactor class cell culture apparatus and produced the method for anti-CD52 monoclonal antibody by this device, it is made to reduce microbiological contamination risk, maintain Growth of Cells ambient stable, keep cell consistent growth vigor, reach high-quality, object that high-efficiency and continuous produces anti-CD52 monoclonal antibody.
Describing cell for traditional technology cell state " good " and " bad " is a kind of colloquial expression, and " lag period ", " logarithmic phase " and " plateau " etc. speech be also a comparatively general concept, not accurately and accurate.The present invention uses specific cell growth rate (μ) as the kinetic parameter accurately describing Growth of Cells, can reflect cell state to a certain extent.According to the result of study of contriver, this growth velocity equation and cell cycle distribution, cell residence time within the cell cycle are substantial connection, regulated, can realize the target of accuracy controlling cell state by specific device composition linked system.
Foregoing invention object of the present invention is achieved through the following technical solutions:
A kind of on-line industry Robustness regulation and control cell state produces the device of anti-CD52 monoclonal antibody, in order to taxis regulation and control cell state, this device at least comprises: nutrient solution hold-up vessel, bioreactor can be monitored, harvest product tank, some reason biochemical indicator detectors, online monitoring system, cell state control set for adjusting and linked system, cell retention device, some fluid sterility control speed pushers and some controlled fast pipeline systems, wherein, described nutrient solution hold-up vessel is connected with described bioreactor of monitoring through described fluid sterility control speed pusher by described controlled fast pipeline system, described cell retention device can monitor bioreactor described in connecting, described cell state control set for adjusting and linked system monitor bioreactor through described fluid sterility control speed pusher selectivity with described by described controlled fast pipeline system or described cell retention device is connected, described cell state control set for adjusting and linked system connect described harvest product tank by described controlled fast pipeline system through described fluid sterility control speed pusher, described bioreactor of monitoring connects described online monitoring system by described reason biochemical indicator detector, described online monitoring system is connected with described fluid sterility control speed pusher and carries controls fast instruction to described fluid sterility control speed pusher, above-mentioned all container class devices are all connected by controlled fast pipeline system, wherein, described cell state control set for adjusting and linked system are used for the described regulation and control monitoring different specific cell growth rate and different cell state in bioreactor.
Preferably, described cell retention device comprises concentrating cells outlet and harvested cell outlet, described cell state control set for adjusting and linked system can be selected and one be monitored the tank body of bioreactor with described, the concentrating cells of described cell retention device exports or the harvested cell of described cell retention device exports and is connected, and described cell state control set for adjusting and linked system at least comprise three kinds of work linked manner:
The first, when described cell state control set for adjusting and linked system and the concentrating cells of described cell retention device export be connected time, cell concentrated in described cell retention device can be discharged by the waste discharge cytostome on cell retention device by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor;
The second, when described cell state control set for adjusting and linked system are directly connected with the described tank body monitoring bioreactor, the described cell monitored in bioreactor can be discharged by the described waste discharge mouth monitored on bioreactor, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor by it;
The third, when described cell state control set for adjusting and linked system and the harvested cell of described cell retention device export be connected time, the cell of different concns can be discharged by the harvested cell outlet as the cell retention device of waste discharge cytostome when the difference of described cell retention device retains efficiency state by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor.
In the preferred embodiment of the present invention, described cell state control set for adjusting and linked system comprise the regulator control system of cellular segregation reflux unit and cell deliverying unit and cell state, described cellular segregation reflux unit is positioned on described cell retention device, and it controls cell return velocity by fluid sterility control speed pusher; Described cell deliverying unit selectivity is positioned at concentrating cells outlet, the harvested cell outlet of described cell retention device or describedly monitors on the cell relief outlet of bioreactor; The regulator control system of described cell state by the set point feedback of described online monitoring system to the fluid sterility control speed pusher of described cell deliverying unit, control the speed of cell discharge and the cell concentration of discharge, when after the discharge cell concentration that the cell concentration regulator control system that reaches described cell state of discharging provides, fluid sterility control speed pusher quits work.
Above-mentioned on-line industry Robustness regulation and control cell state of the present invention produces the device of anti-CD52 monoclonal antibody, also can be used for the production except other external antibody of anti-CD52 monoclonal anti simultaneously.
The invention also discloses a kind of method that on-line industry Robustness regulation and control cell state produces anti-CD52 monoclonal antibody, the method includes the steps of:
1) sterilizing is carried out to cell culture system, then in cell culture system, pass into aseptic PBS damping fluid or aseptic culture fluid, the whole cell culture system of wash cycles;
2) to inoculating cell suspension in cell culture apparatus, the elementary cultivation of cell is carried out;
3) when Growth of Cells increases the cell density 1 ~ 100 × 10 of applicable expression recombinant protein
6during individual cell/ml and cell viability more than 70%, according to the growth characteristics of culturing cell, the parameters of biochemical marker data setting online monitoring system is managed in the cell culture apparatus that the working volume of cell culture apparatus and online monitoring system detect, described online monitoring system is expressed process to the anti-CD52 monoclonal antibody of perfusion culture and is automatically controlled, indices in cell culture apparatus is maintained the best reason biochemical condition of setting, and regulate the corresponding fluid sterility control speed pusher of cell state control set for adjusting and linked system, it is the optimum cell state of expressing anti-CD52 monoclonal antibody by cell state regulable control, whole system is made to reach the index of stable state, simultaneously automatic monitoring and record whole cell cultures and anti-CD52 monoclonal antibody expresses process,
4), after having produced, stop cultivating, product reclaims purifying.In addition, closedown online monitoring system is also comprised, the conventional steps such as cleaning culture apparatus.
Wherein preferred, described step 2) in, the cell inoculated is one of the following engineering cell for the production of anti-CD52 monoclonal antibody: CHO, HEK293, BHK or Per are C.6.
Preferably, described step 2) in, the inoculum density of inoculating cell suspension is 0.5 ~ 5 × 10
6individual cell/ml.
Preferably, in described step 3), described reason biochemical marker data comprises cellular metabolism, cell growth rate, Product formation balance regulation data, those data are obtained by on-line monitoring glucose, lactic acid, L-glutamic acid, paddy ammonia phthalein amine, oxygen consumption rate and pH value index, monitor specific cell growth rate and protein ratio generating rate simultaneously.
Preferably, in described step 3), the method detecting the reason biochemical marker data in cell culture apparatus is: make the nutrient solution in cell culture apparatus not have reason biochemical indicator detector set to detect, and the signal data after reason biochemical indicator detector is detected and changed returns to online monitoring system.
Preferably, in described step 3), the index that reason biochemical indicator detector set can detect at least comprises: temperature, pH value, dissolved oxygen, molten carbonic acid gas, glucose, lactic acid, cell density, ammonia index.
Preferably, in described step 3), online monitoring system is expressed process to the anti-CD52 monoclonal antibody of perfusion culture and is carried out automatically controlling to comprise: online monitoring system receives reason biochemical marker data and processes, then send instruction and automatically regulate the interpolation speed of fresh pre-treatment nutrient solution and the useless cell velocity of discharge, the reason biochemical indicator maintaining cell culture environment is the best reason biochemical condition of setting, wherein, the interpolation speed of fresh pre-treatment nutrient solution is the velocity of discharge and the waste discharge cytostome flow velocity sum of cell retention device upper liquid outlet.
Preferably, in described step 3), described the best reason biochemical condition at least comprises: nutrient solution adds the serum (v/v) of 10%-20%, if use serum-free medium, does not then add serum; Culture-liquid temp 34.5 DEG C ± 5.5 DEG C, pH value 7.0 ± 2.0, dissolved oxygen 10% ~ 65%, molten carbonic acid gas 5% ± 8%.
Preferably, in described step 3), the cell state index of online monitoring system regulable control at least comprises: specific cell growth rate, cell cycle distribution, cell cycle mean residence time.
Preferably, in described step 3), the optimum cell state of expressing anti-CD52 monoclonal antibody at least comprises: G0/G1 cell cycle, cell phase accounts for 20% ~ 85%, S phase cell accounts for 5% ~ 70%, G2/M phase cell accounts for 1% ~ 30% and its summation is 100%, cell G0/G1 phase mean residence time 2 hours ~ 80 hours, S phase mean residence time 4 hours ~ 40 hours, G2/M phase mean residence time 1 hour ~ 20 hours.
Preferably, in described step 3), the index of the stable state of described whole system mainly refers to lactic acid generating rate, glucose consumption rate ratio, and the value of specific cell growth rate keeps basicly stable.
Preferably, in described step 3), automatic monitoring and record whole cell cultures and expression of recombinant proteins process is: setting online monitoring system records each index probe monitors data and equipment operating parameter automatically, and the self registering timed interval is 5 ~ 300 seconds, and stores data.
Preferably, the process of described step 3) is carried out in the elementary cultivation of cell or secondary cultivation stage.
Preferably, in described step 4), judge that the standard of having produced is: Cell viability declines, or total cellular score declines obviously, or protein expression obviously reduces, the preliminary experiment before amplifying by technique is determined in conjunction with the service data of whole system.
Compared with prior art, beneficial effect of the present invention is as follows:
One provided by the invention both can online, continuously, multiple reason biochemical indicator in monitoring cell culture environment, again can directly the bio-reactor class cell culture apparatus of regulation and control cell state (comprising the cell cycle etc.) and the method for being produced by this device, anti-CD52 monoclonal antibody production process is made to reduce microbiological contamination risk, maintain Growth of Cells ambient stable, keep cell consistent growth vigor, reach high-quality, object that high-efficiency and continuous produces anti-CD52 monoclonal antibody.
Accompanying drawing explanation
Fig. 1 is cell cycle schematic diagram;
Fig. 2 is that the present invention realizes to produce the schematic diagram of a kind of embodiment of the device of anti-CD52 monoclonal antibody by on-line industry Robustness (industrially robust) regulation and control cell state;
Fig. 3 is the elementary cultivation of the cell of example 1 of the present invention and secondary culturing process growth kinetics of cells figure;
Fig. 4 is the elementary cultivation of the cell of example 1 of the present invention and secondary culturing process cell cycle distribution histogram;
Fig. 5 is the secondary culturing process anti-CD52 monoclonal antibody expression figure of example 1 of the present invention;
Fig. 6 shows culturing process growth kinetics of cells before the cell transfecting of example 2 of the present invention;
Before Fig. 7 shows the cell transfecting of example 2 of the present invention, culturing process cell state controls result;
Fig. 8 a and Fig. 8 b shows the elementary cultivation of the cell of example 2 of the present invention and secondary culturing process cellular metabolism;
Fig. 9 is culturing process anti-CD52 monoclonal antibody expression figure after example 2 of the present invention transfection.
Embodiment
Above description general description content of the present invention; several specific embodiments below will more directly embody situation of the present invention; but it must be noted that; the object be illustrated is only used at this example enumerated; the present invention is not limited thereto; the changes that any person skilled in the art can think of, all should drop in protection scope of the present invention.
That uses in following examples can refer to Fig. 2 by on-line control and control CHO or the HEK293 cell state device of producing anti-CD52 monoclonal antibody, it mainly comprises: nutrient solution hold-up vessel, bioreactor can be monitored, harvest product tank (in corresponding diagram supernatant liquor results tank), connect and be arranged on the some reason biochemical indicator detectors can monitored on bioreactor, online monitoring system (in corresponding diagram on-line monitoring terminal), (mode of operation comprises linked manner one for cell state control set for adjusting and linked system, linked manner two and linked manner three), cell retention device, some fluid sterility control speed pushers and some controlled fast pipeline systems, wherein, described nutrient solution hold-up vessel is connected with described bioreactor of monitoring through described fluid sterility control speed pusher by described controlled fast pipeline system, described cell retention device can monitor bioreactor described in connecting, described cell state control set for adjusting and linked system monitor bioreactor through described fluid sterility control speed pusher selectivity with described by described controlled fast pipeline system or described cell retention device is connected, described cell state control set for adjusting and linked system connect described harvest product tank by described controlled fast pipeline system through described fluid sterility control speed pusher, described bioreactor of monitoring connects described online monitoring system by described reason biochemical indicator detector, described online monitoring system is connected with described fluid sterility control speed pusher and carries controls fast instruction to described fluid sterility control speed pusher, above-mentioned all container class devices are all connected by controlled fast pipeline system, wherein, described cell state control set for adjusting and linked system are used for the described regulation and control monitoring different specific cell growth rate and different cell state in bioreactor.It should be noted that the object of this schematic diagram 2 helps better to understand the present invention, and not show the form that apparatus and method of the present invention are only confined to this accompanying drawing and show.
Wherein, described cell retention device comprises concentrating cells outlet and harvested cell outlet, described cell state control set for adjusting and linked system can be selected and one be monitored the tank body of bioreactor with described, the concentrating cells of described cell retention device exports or the harvested cell of described cell retention device exports and is connected, described cell state control set for adjusting and linked system at least comprise three kinds of work linked manner, incorporated by reference to Fig. 2:
The first (in corresponding diagram 2 linked manner one), when described cell state control set for adjusting and linked system and the concentrating cells of described cell retention device export be connected time, cell concentrated in described cell retention device can be discharged by the waste discharge cytostome on cell retention device by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor;
The second (in corresponding diagram 2 linked manner two), when described cell state control set for adjusting and linked system are directly connected with the described tank body monitoring bioreactor, the described cell monitored in bioreactor can be discharged by the described waste discharge mouth monitored on bioreactor, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor by it;
The third (in corresponding diagram 2 linked manner three), when described cell state control set for adjusting and linked system and the harvested cell of described cell retention device export be connected time, the cell of different concns can be discharged by the harvested cell outlet as the cell retention device of waste discharge cytostome when the difference of described cell retention device retains efficiency state by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor.
Described cell state control set for adjusting and linked system comprise the regulator control system of cellular segregation reflux unit and cell deliverying unit and cell state, described cellular segregation reflux unit can be cell refluxing opening, it is positioned on described cell retention device, and controls cell return velocity by fluid sterility control speed pusher; Described cell deliverying unit can be useless cell relief outlet, and its selectivity is positioned at the concentrating cells outlet of described cell retention device, harvested cell outlet or describedly monitors on the cell relief outlet of bioreactor; The regulator control system of described cell state by the set point feedback of described online monitoring system to the fluid sterility control speed pusher of described cell deliverying unit, control the speed of cell discharge and the cell concentration of discharge, when after the discharge cell concentration that the cell concentration regulator control system that reaches described cell state of discharging provides, fluid sterility control speed pusher quits work.
Wherein, specifically in the examples below, nutrient solution hold-up vessel is common cylinder or square body bottle structure, in order to hold aseptic culture medium, its outlet is tightly connected with described controlled fast pipeline system, and described nutrient solution hold-up vessel is communicated with air by the sterilised membrane filter strainer that interface that its tank body is arranged and described interface are arranged.
Can monitor bioreactor is general commercial bioreactor, possess multiple reason biochemical indicator probe interface, multiple liquid entrance and multiple gas inlet and outlet, can aseptically use or change fluidic interface or the gas interface of different number, enter to carry different liquid stream or gas or leave and described can monitor bioreactor, and different reason biochemical indicator probe groups can be selected.In addition, bioreactor can be monitored and also the quantity of liquid entrance or gas inlet and outlet according to actual needs can be set to one.In addition the self-control animal bioreactor possessing above-mentioned said function can also be used.
Reason biochemical indicator detector is all selected from commercial reason biochemical indicator detector, as detecting electrode, it possesses capacity switching signal, the reason biochemical indicator numbers translate that reason biochemical indicator sensor detects can be signal and transfer to described online monitoring system, each reason biochemical indicator detector is connected with described online monitoring system by electrode cable, wherein manages biochemical indicator detector and at least comprises pH value, temperature, dissolved oxygen, molten CO
2, osmotic pressure, cell density, glucose, lactic acid, ammonia index, liquid level detector one or more.In addition the self-control reason biochemical indicator detector possessing above-mentioned said function can also be used.
Fluid sterility control speed pusher is selected from commodity peristaltic pump, liquid-flow can be promoted with the speed of setting, flow velocity signal can be transferred to described online monitoring system, automatically regulate operating power to reach the object controlling different in flow rate or stop flowing by manual or described online monitoring system.In addition the controlled fast fluid forces device of the self-control possessing above-mentioned said function can also be used.
Online monitoring system is selected from commercial control tower, the function of the signal that it possesses the signal receiving described reason biochemical indicator sensor transmissions, described fluid control speed pusher transmits, and signal conversion processes function, reason biochemical indicator and fluid control speed pusher steering order send function, data logging memory function, and there is complete human-computer interaction interface.In addition the self-control online monitoring system possessing above-mentioned said function can also be used.
Controlled fast pipeline system forms pipeline system body by the ordinary silicon sebific duct meeting recombinant protein Production requirement and pipeline system body between any two container class devices is all with slides control speed folder or controls fast valve, described slip control speed folder or control fast valve and be located at related device exit.In addition, ordinary silicon sebific duct can also replace with high-molecular polymerization membrane material pipe.
In following examples, the on-line industry Robustness regulation and control cell state using said apparatus to carry out cell cultures produces the method for anti-CD52 monoclonal antibody, comprises following steps:
1) sterilizing is carried out to cell culture system, then in cell culture system, pass into aseptic PBS damping fluid or aseptic culture fluid, the whole cell culture system of wash cycles;
2) to inoculating cell suspension in cell culture apparatus, the elementary cultivation of cell is carried out;
3) when Growth of Cells increases the cell density 1 ~ 100 × 10 of applicable expression recombinant protein
6during individual cell/ml and cell viability more than 70%, according to the growth characteristics of culturing cell, the parameters of biochemical marker data setting online monitoring system is managed in the cell culture apparatus that the working volume of cell culture apparatus and online monitoring system detect, described online monitoring system is expressed process to the anti-CD52 monoclonal antibody of perfusion culture and is automatically controlled, indices in cell culture apparatus is maintained the best reason biochemical condition of setting, and regulate the corresponding fluid sterility control speed pusher of cell state control set for adjusting and linked system, it is the optimum cell state of expressing anti-CD52 monoclonal antibody by cell state regulable control, whole system is made to reach the index of stable state, simultaneously automatic monitoring and record whole cell cultures and anti-CD52 monoclonal antibody expresses process,
4), after having produced, stop cultivating, product reclaims purifying.
Wherein, described step 2) in, the cell inoculated is one of the following engineering cell for the production of anti-CD52 monoclonal antibody: CHO, HEK293, BHK or Per are C.6; The inoculum density of inoculating cell suspension is 0.5 ~ 5 × 10
6individual cell/ml.
In described step 3), described reason biochemical marker data comprises cellular metabolism, cell growth rate, Product formation balance regulation data, those data are obtained by on-line monitoring glucose, lactic acid, L-glutamic acid, paddy ammonia phthalein amine, oxygen consumption rate and pH value index, monitor specific cell growth rate and protein ratio generating rate simultaneously; The method detecting the reason biochemical marker data in cell culture apparatus is: make the nutrient solution in cell culture apparatus not have reason biochemical indicator detector set to detect, and the signal data after reason biochemical indicator detector is detected and changed returns to online monitoring system; The index that above-mentioned reason biochemical indicator detector set can detect at least comprises: temperature, pH value, dissolved oxygen, molten carbonic acid gas, glucose, lactic acid, cell density, ammonia index.
In described step 3), online monitoring system is expressed process to the anti-CD52 monoclonal antibody of perfusion culture and is carried out automatically controlling to comprise: online monitoring system receives reason biochemical marker data and processes, then send instruction and automatically regulate the interpolation speed of fresh pre-treatment nutrient solution and the useless cell velocity of discharge, the reason biochemical indicator maintaining cell culture environment is the best reason biochemical condition of setting, wherein, the interpolation speed of fresh pre-treatment nutrient solution is the velocity of discharge and the waste discharge cytostome flow velocity sum of cell retention device upper liquid outlet.
In described step 3), described the best reason biochemical condition at least comprises: nutrient solution adds the serum (v/v) of 10%-20%, if use serum-free medium, does not then add serum; Culture-liquid temp 34.5 DEG C ± 5.5 DEG C, pH value 7.0 ± 2.0, dissolved oxygen 10% ~ 65%, molten carbonic acid gas 5% ± 8%.
In described step 3), the cell state index of online monitoring system regulable control at least comprises: specific cell growth rate, cell cycle distribution, cell cycle mean residence time.
In described step 3), the optimum cell state of expressing anti-CD52 monoclonal antibody at least comprises: G0/G1 cell cycle, cell phase accounts for 20% ~ 85%, S phase cell accounts for 5% ~ 70%, G2/M phase cell accounts for 1% ~ 30% and its summation is 100%, cell was G0/G1 phase mean residence time 2 hours ~ 80 hours, S phase mean residence time 4 hours ~ 40 hours, G2/M phase mean residence time 1 hour ~ 20 hours.
In described step 3), the index of the stable state of described whole system mainly refers to lactic acid generating rate, glucose consumption rate ratio, and the value of specific cell growth rate keeps basicly stable.
In described step 3), automatic monitoring and record whole cell cultures and expression of recombinant proteins process is: setting online monitoring system records each index probe monitors data and equipment operating parameter automatically, the self registering timed interval is 5 ~ 300 seconds, and stores data.
The process of described step 3) is carried out in the elementary cultivation of cell or secondary cultivation stage.
In described step 4), judge that the standard of having produced is: Cell viability declines, or total cellular score declines obviously, or protein expression obviously reduces, the preliminary experiment before amplifying by technique is determined in conjunction with the service data of whole system.
Following examples some specific exampless for using on-line industry Robustness of the present invention (industrially robust) regulation and control Chinese hamster ovary celI state to produce the method for anti-CD52 monoclonal antibody.
Example 1, the method for anti-CD52 monoclonal antibody can be produced by on-line industry Robustness (industrially robust) regulation and control Chinese hamster ovary celI state bio-reactor
The related reagent used in this example and device as follows:
Nutrient solution: the Excell CD CHO serum-free medium that U.S. Sigma produces;
Cell: the Chinese hamster ovary celI of expressing the anti-CD52 monoclonal antibody of restructuring stablizes strain;
Bioreactor can be monitored: the 7L zooblast reactor that Dutch Applicon company produces, working volume 5L;
Online monitoring system: the control tower that Dutch Applicon company produces.
The method of producing anti-CD52 monoclonal antibody in this example is as follows:
1) design temperature 37 DEG C on the control tower of Dutch Applicon company production, pH value 7.1, oxyty value 45%, molten gas concentration lwevel 5%, by heating jacket control temperature, the flow valve on control tower is control CO automatically
2, N
2, O
2the method of AIR tetra-tunnel air inlet bubbling oxygen supply controls oxyty and molten gas concentration lwevel, peristaltic pump control tower being connected with 1mol/L NaOH and 1mol/L HCL controls pH value, adds nutrient solution to the speed of peristaltic pump of cell culture apparatus can monitoring bioreactor according to the signal control of level electrode (control liquid level), the tank body can monitoring bioreactor is connected with the liquid inlet of supplementary fresh medium, this liquid inlet connects nutrient solution hold-up vessel, bioreactor can be monitored be connected with the cell state setting device of external placed type simultaneously, this cell state control set for adjusting comprises cellular segregation reflux unit and cell deliverying unit, the regulator control system of this cell state control set for adjusting and cell state constitutes cell state control set for adjusting and linked system jointly, cell state control set for adjusting is also connected to be expelled to by the supernatant liquor of results in this harvest product tank with harvest product tank (herein for tank gathered in the crops by supernatant liquor), complete assembly has been connected and installed latter 121 DEG C, high pressure steam sterilization 20min, is placed in sterilisable chamber, then in system, passes into aseptic PBS damping fluid, wash cycles whole system, subsequently, discharge PBS, add fresh medium, circulation 24h, check whether microbiological contamination and system run all right, check aseptic after, by nutrient solution process to set(ting)value, even with the index of the velocity interpolation nutrient solution of 80RPM,
2) the elementary cultivation of cell
With 1 × 10
6the density of individual cell/ml prepares cell suspension, to monitoring in bioreactor inoculating cell suspension to final concentration 3 × 10
5individual cell/ml, batch cultivation, after 96 hours, treats that cell amplification is to 5 × 10
6open perfusion during the density of individual cell/ml, perfusion rate is set to 0.5 reactor tank body volume/sky (i.e. 2.5L/ days), continuation culturing cell 72 hours, culturing cell density to 9 × 10
6individual cell/ml, continues cultivation 96 hours afterwards again, and irrigation rate is 1 reactor tank body volume/sky (i.e. 5L/ days), and cell density can reach 30 × 10
6individual cell/ml, cell viability more than 95%, this result can see Fig. 3;
3) the secondary cultivation of cell and expressing protein
After elementary cultivation completes, design temperature 35 DEG C on control tower, pH value 7.0, oxyty value 35%, molten gas concentration lwevel 5%, carry out perfusion to cultivate and Restruction protein process, perfusion initial rate is set to 2 reactor tank body volume/skies (i.e. 10L/ days), data measured by glucose electrode carry out dynamic adjustments, glucose concn in nutrient solution is maintained 2g/L, the simultaneously online monitoring system fast pusher of fluid sterility control that regulates the cell refluxing opening (being one of embodiment of cellular segregation reflux unit) of cell state control set for adjusting and linked system to be connected with useless cell relief outlet (being one of embodiment of cell deliverying unit), useless cell relief outlet flow velocity is set to 1.5L/ days, see Fig. 4, be specific cell growth rate by cell state regulable control be 0.34d
-1, S phase cell in the cell cycle, G0/G1 phase cell and G2/M phase cell proportion are respectively 12.01%, 49.10% and 38.09%, cell was G0/G1 phase mean residence time 5 hours, S phase mean residence time 8 hours, G2/M phase mean residence time 4 hours, cell density reaches 3 × 10
7individual cell/ml, cell viability more than 95%, see Fig. 3.Harvest product tank cultivates with phase same rate results the supernatant liquor obtained accordingly, every day samples, to cell density, cell viability and expressing quantity detect, automatic monitoring and the probe monitors data and the equipment operating parameter that record each reason biochemical indicator detector in whole cell cultures and protein expression production process simultaneously, arranges control tower every 30 seconds record one secondary data and stores;
4) produced
According to the data of control tower record, the peristaltic pump rotating speed substantially constant of perfusion nutrient solution fluid inlet and liquid outlet, remain on 2 reactor tank body volume/skies, cell density maintains 30 × 10
6individual cell/ml, cell viability more than 95%, continuously perfused culture, after 20 days, after obtaining enough albumen, gathers in the crops whole supernatant liquor, stops the process of cell cultures and expressing protein.Carry out next step protein purification, quality test and preparation set-up procedure.And close online monitoring system, cleaning culture apparatus etc. simultaneously.Judge in this step that the standard of having produced is: Cell viability declines, or total cellular score declines obviously, or protein expression obviously reduces.
Find according to the physico-chemical property detected result of results albumen, gather in the crops the purity of albumen and activity is all cultivated with conventional batch or Fed batch fementation is similar, but because cell density and expression amount are better, so finally gathered in the crops more high reactivity high purity protein, protein yield has significantly improved.Refer to Fig. 5, use culture apparatus and the technique of this embodiment of the invention, regulate the irrigation rate of cell cultures, cell keeps good growth conditions, expressing protein from the 5th day, is efficiently maintained to the 30th day always, cytoactive is good, expression amount maintains higher state, and every system control parameters is good, belongs to higher level in the technique of report at present.
Apparatus and method of the present invention not only can be used for producing anti-CD52 monoclonal antibody based on the bioreactor processes of stable recombinant cell strain, and also may be used for various astable recombinant cell strain bioreactor processes (biological example reactor gene transfection transient expression process) produces anti-CD52 monoclonal antibody simultaneously.Below be namely specific embodiment.
Example 2, bio-reactor gene transfection transient expression process can be regulated and controled to produce anti-CD52 monoclonal antibody by on-line industry Robustness (industrially robust)
The reagent used in this example and instrument as follows:
Nutrient solution: the Excell293 serum-free medium that U.S. Sigma produces;
Cell: serum free suspension domestication HEK293 cell strain;
Bioreactor can be monitored: the 3L zooblast reactor that Dutch Applikon company produces, working volume 2.1L;
Online monitoring system: the control tower that Dutch Applicon company produces.
The method of producing anti-CD52 monoclonal antibody in this example is as follows:
1) design temperature 37 DEG C on the control tower of Dutch Applikon company production, pH value 7.4, oxyty value 40%, molten gas concentration lwevel 5%, by thermostatic water-jacket control temperature, the flow valve on control tower is control CO automatically
2, N
2, O
2three tunnel air inlets, oxyty and molten gas concentration lwevel is controlled by the method for overlay oxygen supply, peristaltic pump control tower being connected with 1mol/L NaOH and 1mol/L HCL controls pH value, the speed of nutrient solution to the peristaltic pump of cell culture apparatus is added according to the signal control of level electrode (Liquid level), bioreactor can be monitored by what its tank body was arranged and supplement fresh medium with the liquid inlet that nutrient solution hold-up vessel is directly connected, can monitor bioreactor also with cell retention device, cell state control set for adjusting and linked system, harvest product tank (being herein supernatant liquor results tank) is connected, the supernatant liquor of results is expelled in supernatant liquor results tank, complete assembly has been connected and installed latter 121 DEG C, high pressure steam sterilization 20min, be placed in sterilisable chamber, then in system, aseptic PBS damping fluid is passed into, wash cycles whole system.Subsequently, discharge PBS, add fresh medium, circulation 24h, check whether microbiological contamination and system run all right.Check aseptic after, by nutrient solution process to set(ting)value, even with the index of the velocity interpolation nutrient solution of 60RPM;
2) the elementary cultivation of cell
With 1 × 10
6the density of individual cell/ml prepares cell suspension, and in 3L bio-reactor, inoculating cell suspension is to final concentration 3 × 10
5individual cell/ml, cultivates 48 hours when not carrying out perfusion cultivation, treats that cell amplification is to 2 × 10
6perfusion is opened during the density of individual cell/ml, data measured by glucose electrode carry out dynamically arranging irrigation rate from 0.5L/ days ~ 4L/ days, glucose concn in nutrient solution is maintained 2g/L, the fluid sterility control speed pusher simultaneously regulating the refluxing opening (being one of embodiment of cellular segregation reflux unit) of cell state control set for adjusting and linked system to be connected with useless cell relief outlet (being one of embodiment of cell deliverying unit), regulating cell state, the initial launch speed of cell state control set for adjusting and linked system is set to 0.3 reactor tank body volume/sky (i.e. 0.63L/ days), continue to cultivate, perfusion rate constantly increases to 0.85 reactor tank body volume/sky from 0.1 retort volume, continue culturing cell 7 days, be specific cell growth rate by cell state regulable control be 0.88d
-1, S phase cell in the cell cycle, G0/G1 phase cell and G2/M phase cell proportion are respectively 37.26%, 48.61% and 14.13%, see Fig. 7, cell is in the G0/G1 phase, and the residence time of S phase and G2/M phase is respectively 10.23 hours, 7.84 hours and 3.13 hours, and cell density reaches 6 × 10
6individual cell/ml, cell viability more than 95%, see Fig. 6, in whole process, the metabolic condition of cell is as figures 8 a and 8 b show,
3) the secondary cultivation of cell and cell transfecting express recombinant protein
After elementary cultivation completes, by cell regulate and control to exact state, design temperature 33 DEG C on control tower, pH value 7.0, oxyty value 40%, molten gas concentration lwevel 5%, stop perfusion system and cell state control set for adjusting and linked system, regulate cell density to 1 × 10
6individual cell/mL, carry out cell transfecting and Restruction protein process, every day samples, to cell density, cell viability and expressing quantity detect, carry out secondary cultivation and the protein expression process of cell, simultaneously automatic monitoring and record whole cell cultures and protein expression production process, control tower every 30 seconds record one secondary data are set and store;
4) produced
According to the data of control tower record, after transfection, the 5th day cell density reaches maximum value, and cell density is 6.3 × 10
6individual cell/mL, anti-CD52 monoclonal antibody expression amount reaches maximum on the 4th day after transfection, and continuously perfused culture gathers in the crops whole supernatant liquor after within 10 days, obtaining enough albumen afterwards, stops the process of cell cultures and expressing protein.Carry out next step protein purification, quality test and preparation set-up procedure.And close online monitoring system, cleaning culture apparatus etc. simultaneously.
Gathered in the crops albumen is detected, purity of protein is more than 95%, protein-active is good, meet the albumen stoste quality standard that national legislation requires, because this system accurately controls to cultivate by pouring into and controlling cell physiological biochemical parameter, final incubation time extends, and the protein quantity of results significantly improves, and this system has better using value.As Fig. 9, after transfection, cell density maintains higher level, and protein expression reached maximum at the 3rd day, then last till that cell density declines, the whole process time is long, cell state and activity good, finally gather in the crops albumen more more than legacy system, improve efficiency, reduce cost.
Under the instruction of the present invention and above-described embodiment, those skilled in the art are easy to predict, cited or each raw material that exemplifies of the present invention or its equivalent alterations, each working method or its equivalent alterations can realize the present invention, and the parameter bound value of each raw material and working method, interval value can realize the present invention, do not enumerate embodiment at this.
Claims (26)
1. an on-line industry Robustness regulation and control cell state produces the device of anti-CD52 monoclonal antibody, in order to taxis regulation and control cell state, it is characterized in that, this device at least comprises: nutrient solution hold-up vessel, bioreactor can be monitored, harvest product tank, some reason biochemical indicator detectors, online monitoring system, cell state control set for adjusting and linked system, cell retention device, some fluid sterility control speed pushers and some controlled fast pipeline systems, wherein, described nutrient solution hold-up vessel is connected with described bioreactor of monitoring through described fluid sterility control speed pusher by described controlled fast pipeline system, described cell retention device can monitor bioreactor described in connecting, described cell state control set for adjusting and linked system monitor bioreactor through described fluid sterility control speed pusher selectivity with described by described controlled fast pipeline system or described cell retention device is connected, described cell state control set for adjusting and linked system connect described harvest product tank by described controlled fast pipeline system through described fluid sterility control speed pusher, described bioreactor of monitoring connects described online monitoring system by described reason biochemical indicator detector, described online monitoring system is connected with described fluid sterility control speed pusher and sends controls fast instruction to described fluid sterility control speed pusher, above-mentioned all container class devices are all connected by controlled fast pipeline system, wherein, described cell state control set for adjusting and linked system are used for the described regulation and control monitoring different specific cell growth rate and different cell state in bioreactor.
2. on-line industry Robustness regulation and control cell state as claimed in claim 1 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described cell retention device comprises concentrating cells outlet and harvested cell outlet, described cell state control set for adjusting and linked system can be selected and one be monitored the tank body of bioreactor with described, the concentrating cells of described cell retention device exports or the harvested cell of described cell retention device exports and is connected, and described cell state control set for adjusting and linked system at least comprise three kinds of work linked manner:
The first, when described cell state control set for adjusting and linked system and the concentrating cells of described cell retention device export be connected time, cell concentrated in described cell retention device can be discharged by the waste discharge cytostome on cell retention device by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor;
The second, when described cell state control set for adjusting and linked system are directly connected with the described tank body monitoring bioreactor, the described cell monitored in bioreactor can be discharged by the described waste discharge mouth monitored on bioreactor, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor by it;
The third, when described cell state control set for adjusting and linked system and the harvested cell of described cell retention device export be connected time, the cell of different concns can be discharged by the harvested cell outlet as the cell retention device of waste discharge cytostome when the difference of described cell retention device retains efficiency state by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor.
3. on-line industry Robustness regulation and control cell state as claimed in claim 2 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described cell state control set for adjusting and linked system comprise the regulator control system of cellular segregation reflux unit and cell deliverying unit and cell state, described cellular segregation reflux unit is positioned on described cell retention device, and it controls cell return velocity by fluid sterility control speed pusher; Described cell deliverying unit selectivity is positioned at concentrating cells outlet, the harvested cell outlet of described cell retention device or describedly monitors on the cell relief outlet of bioreactor; The regulator control system of described cell state by the set point feedback of described online monitoring system to the fluid sterility control speed pusher of described cell deliverying unit, control the speed of cell discharge and the cell concentration of discharge, when after the discharge cell concentration that the cell concentration regulator control system that reaches described cell state of discharging provides, fluid sterility control speed pusher quits work.
4. on-line industry Robustness regulation and control cell state as claimed in claim 1 or 2 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described nutrient solution hold-up vessel is common cylinder or square body bottle structure, in order to hold aseptic culture medium, its outlet is tightly connected with described controlled fast pipeline system, and described nutrient solution hold-up vessel is communicated with air by the sterilised membrane filter strainer that interface that its tank body is arranged and described interface are arranged.
5. on-line industry Robustness regulation and control cell state as claimed in claim 1 or 2 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described bioreactor of monitoring is general commercial bioreactor or self-control animal bioreactor, possesses one or more reason biochemical indicator probe interface, one or more liquid entrance and one or more gas inlet and outlet, can aseptically use or change fluidic interface or the gas interface of different number, enter to carry different liquid stream or gas or leave and described can monitor bioreactor, and different reason biochemical indicator sensor groups can be selected.
6. on-line industry Robustness regulation and control cell state as claimed in claim 5 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described reason biochemical indicator detector is all selected from commercialization or self-control reason biochemical indicator detector, possesses capacity switching signal, the reason biochemical indicator numbers translate that reason biochemical indicator sensor detects can be signal and transfer to described online monitoring system, each reason biochemical indicator detector is connected with described online monitoring system by electrode cable.
7. the on-line industry Robustness regulation and control cell state as described in claim 1 or 2 or 6 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described reason biochemical indicator detector at least comprises pH value, temperature, dissolved oxygen, molten CO
2, osmotic pressure, cell density, glucose, lactic acid, ammonia index, liquid level detector one or more.
8. on-line industry Robustness regulation and control cell state as claimed in claim 1 or 2 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described fluid sterility control speed pusher is selected from commodity peristaltic pump or makes controlled fast fluid forces device by oneself, liquid-flow can be promoted with the speed of setting, flow velocity signal can be transferred to described online monitoring system, automatically regulate operating power to reach the object controlling different in flow rate or stop flowing by manual or described online monitoring system.
9. on-line industry Robustness regulation and control cell state as claimed in claim 1 or 2 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described online monitoring system is selected from commercial control tower or self-control online monitoring system, the function of the signal that it possesses the signal receiving described reason biochemical indicator sensor transmissions, described fluid control speed pusher transmits, and signal conversion processes function, reason biochemical indicator sensor and fluid control speed pusher are sent to the function of steering order, data logging memory function, and there is complete human-computer interaction interface.
10. on-line industry Robustness regulation and control cell state as claimed in claim 1 or 2 produces the device of anti-CD52 monoclonal antibody, it is characterized in that, described controlled fast pipeline system forms pipeline system body by the ordinary silicon sebific duct or high-molecular polymerization membrane material pipe that meet recombinant protein Production requirement and pipeline system body between any two container class devices is all with slides control speed folder or controls fast valve, described slip control speed folder or control fast valve and be located at related device exit.
11. 1 kinds of on-line industry Robustness regulation and control cell states produce the method for anti-CD52 monoclonal antibody, it is characterized in that, comprise following steps:
1) sterilizing is carried out to cell culture system, then in cell culture system, pass into aseptic PBS damping fluid or aseptic culture fluid, the whole cell culture system of wash cycles;
2) to inoculating cell suspension in cell culture apparatus, the elementary cultivation of cell is carried out;
3) when Growth of Cells increases the cell density 1 ~ 100 × 10 of applicable expression recombinant protein
6during individual cell/ml and cell viability more than 70%, according to the growth characteristics of culturing cell, the parameters of biochemical marker data setting online monitoring system is managed in the cell culture apparatus that the working volume of cell culture apparatus and online monitoring system detect, described online monitoring system is expressed process to the anti-CD52 monoclonal antibody of perfusion culture and is automatically controlled, indices in cell culture apparatus is maintained the best reason biochemical condition of setting, and regulate the corresponding fluid sterility control speed pusher of cell state control set for adjusting and linked system, it is the optimum cell state of expressing anti-CD52 monoclonal antibody by cell state regulable control, whole system is made to reach the index of stable state, simultaneously automatic monitoring and record whole cell cultures and anti-CD52 monoclonal antibody expresses process,
4), after having produced, stop cultivating, product reclaims purifying.
12. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, described step 2) in, the inoculum density of inoculating cell suspension is 0.5 ~ 5 × 10
6individual cell/ml.
13. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), described reason biochemical marker data comprises cellular metabolism, cell growth rate, Product formation balance regulation data, those data are obtained by on-line monitoring glucose, lactic acid, L-glutamic acid, paddy ammonia phthalein amine, oxygen consumption rate and pH value index, monitor specific cell growth rate and protein ratio generating rate simultaneously.
14. on-line industry Robustness regulation and control cell states according to claim 11 or 13 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), the method detecting the reason biochemical marker data in cell culture apparatus is: make the nutrient solution in cell culture apparatus not have reason biochemical indicator detector set to detect, and the signal data after reason biochemical indicator detector is detected and changed returns to online monitoring system.
15. on-line industry Robustness regulation and control cell states according to claim 14 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), the index that reason biochemical indicator detector set can detect at least comprises: temperature, pH value, dissolved oxygen, molten carbonic acid gas, glucose, lactic acid, cell density, ammonia index.
16. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), online monitoring system is expressed process to the anti-CD52 monoclonal antibody of perfusion culture and is carried out automatically controlling to comprise: online monitoring system receives reason biochemical marker data and processes, then send instruction and automatically regulate the interpolation speed of fresh pre-treatment nutrient solution and the useless cell velocity of discharge, the reason biochemical indicator maintaining cell culture environment is the best reason biochemical condition of setting, wherein, the interpolation speed of fresh pre-treatment nutrient solution is the velocity of discharge and the waste discharge cytostome flow velocity sum of cell retention device upper liquid outlet.
17. on-line industry Robustness regulation and control cell states according to claim 11 or 16 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), described the best reason biochemical condition at least comprises: nutrient solution adds the serum (v/v) of 10%-20%, if use serum-free medium, then do not add serum; Culture-liquid temp 34.5 DEG C ± 5.5 DEG C, pH value 7.0 ± 2.0, dissolved oxygen 10% ~ 65%, molten carbonic acid gas 5% ± 8%.
18. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), the cell state index of online monitoring system regulable control at least comprises: specific cell growth rate, cell cycle distribution, cell cycle mean residence time.
19. on-line industry Robustness regulation and control cell states according to claim 11 or 18 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), the optimum cell state of expressing anti-CD52 monoclonal antibody at least comprises: G0/G1 cell cycle, cell phase accounts for 20% ~ 85%, S phase cell accounts for 5% ~ 70%, G2/M phase cell accounts for 1% ~ 30% and its summation is 100%, cell was G0/G1 phase mean residence time 2 hours ~ 80 hours, S phase mean residence time 4 hours ~ 40 hours, G2/M phase mean residence time 1 hour ~ 20 hours.
20. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), the index of the stable state of described whole system mainly refers to lactic acid generating rate, glucose consumption rate ratio, the value of specific cell growth rate keeps basicly stable.
21. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 3), automatic monitoring and record whole cell cultures and expression of recombinant proteins process is: setting online monitoring system records each index probe monitors data and equipment operating parameter automatically, the self registering timed interval is 5 ~ 300 seconds, and stores data.
22. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, the process of described step 3) is carried out in the elementary cultivation of cell or secondary cultivation stage.
23. on-line industry Robustness regulation and control cell states according to claim 11 produce the method for anti-CD52 monoclonal antibody, it is characterized in that, in described step 4), judge that the standard of having produced is: Cell viability declines, or total cellular score declines obviously, or protein expression obviously reduces.
24. 1 kinds of on-line industry Robustness regulation and control cell states produce the device of antibody, in order to taxis regulation and control cell state, it is characterized in that, this device at least comprises: nutrient solution hold-up vessel, bioreactor can be monitored, harvest product tank, reason biochemical indicator detector, online monitoring system, cell state control set for adjusting and linked system, cell retention device, fluid sterility control speed pusher and controlled fast pipeline system, wherein, described nutrient solution hold-up vessel is connected with described bioreactor of monitoring through described fluid sterility control speed pusher by described controlled fast pipeline system, described cell retention device can monitor bioreactor described in connecting, described cell state control set for adjusting and linked system monitor bioreactor through described fluid control speed pusher selectivity with described by described controlled fast pipeline system or described cell retention device is connected, described cell state control set for adjusting and linked system connect described harvest product tank by described controlled fast pipeline system through described fluid sterility control speed pusher, described bioreactor of monitoring connects described online monitoring system by described reason biochemical indicator detector, described online monitoring system is connected with described fluid sterility control speed pusher, above-mentioned all container class devices are all connected by controlled fast pipeline system, wherein, described cell state control set for adjusting and linked system are used for the described regulation and control monitoring different specific cell growth rate and different cell state in bioreactor.
25. on-line industry Robustness regulation and control cell states as claimed in claim 24 produce the device of antibody, it is characterized in that, described cell retention device comprises concentrating cells outlet and harvested cell outlet, described cell state control set for adjusting and linked system can be selected and one be monitored the tank body of bioreactor with described, the concentrating cells of described cell retention device exports or the harvested cell of described cell retention device exports and is connected, and described cell state control set for adjusting and linked system at least comprise three kinds of work linked manner:
The first, when described cell state control set for adjusting and linked system and the concentrating cells of described cell retention device export be connected time, cell concentrated in described cell retention device can be discharged by the waste discharge cytostome on cell retention device by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor;
The second, when described cell state control set for adjusting and linked system are directly connected with the described tank body monitoring bioreactor, the described cell monitored in bioreactor can be discharged by the described waste discharge mouth monitored on bioreactor, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor by it;
The third, when described cell state control set for adjusting and linked system and the harvested cell of described cell retention device export be connected time, the cell of different concns can be discharged by the harvested cell outlet as the cell retention device of waste discharge cytostome when the difference of described cell retention device retains efficiency state by it, to reach the described regulation and control can monitoring different specific cell growth rate and different cell state in bioreactor.
26. on-line industry Robustness regulation and control cell states as claimed in claim 24 produce the device of antibody, it is characterized in that, described cell state control set for adjusting and linked system comprise the regulator control system of cellular segregation reflux unit and cell deliverying unit and cell state, described cellular segregation reflux unit is positioned on described cell retention device, and it controls cell return velocity by fluid sterility control speed pusher; Described cell deliverying unit selectivity is positioned at concentrating cells outlet, the harvested cell outlet of described cell retention device or describedly monitors on the cell relief outlet of bioreactor; The regulator control system of described cell state by the set point feedback of described online monitoring system to the fluid sterility control speed pusher of described cell deliverying unit, control the speed of cell discharge and the cell concentration of discharge, when after the discharge cell concentration that the cell concentration regulator control system that reaches described cell state of discharging provides, fluid sterility control speed pusher quits work.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410052560.1A CN104845881A (en) | 2014-02-17 | 2014-02-17 | Apparatus and method for producing anti-CD52 monoclonal antibodies through online industrially robust regulation of cell states |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410052560.1A CN104845881A (en) | 2014-02-17 | 2014-02-17 | Apparatus and method for producing anti-CD52 monoclonal antibodies through online industrially robust regulation of cell states |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104845881A true CN104845881A (en) | 2015-08-19 |
Family
ID=53845873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410052560.1A Pending CN104845881A (en) | 2014-02-17 | 2014-02-17 | Apparatus and method for producing anti-CD52 monoclonal antibodies through online industrially robust regulation of cell states |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104845881A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111560399A (en) * | 2020-05-22 | 2020-08-21 | 苏州君盟生物医药科技有限公司 | Large-scale transient transfection method for cells |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166067A (en) * | 1988-11-30 | 1992-11-24 | Hitachi, Ltd. | Culturing method, system and apparatus for cell culture |
| JPH06237754A (en) * | 1992-12-25 | 1994-08-30 | Mitsui Toatsu Chem Inc | Cell separator and method for separating cell using the same and cell culture device and method for culturing cell using the same |
| US20040259169A1 (en) * | 2003-06-20 | 2004-12-23 | Lucina Galina-Pantoja | Methods for selection for efficient animal growth |
| US20060275841A1 (en) * | 2004-12-20 | 2006-12-07 | Martin Blankfard | Assay method and apparatus with reduced sample matrix effects |
| CN201626959U (en) * | 2010-02-01 | 2010-11-10 | 中国农业科学院北京畜牧兽医研究所 | Microperfusion Devices for Cell Culture |
| CN103194389A (en) * | 2013-04-16 | 2013-07-10 | 叶永清 | Device and method for in vitro high-density cultivation of erythrocyte |
| CN103305417A (en) * | 2012-03-07 | 2013-09-18 | 无锡药明康德生物技术有限公司 | High-yield reactor for protein production, and production method and application thereof |
-
2014
- 2014-02-17 CN CN201410052560.1A patent/CN104845881A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166067A (en) * | 1988-11-30 | 1992-11-24 | Hitachi, Ltd. | Culturing method, system and apparatus for cell culture |
| JPH06237754A (en) * | 1992-12-25 | 1994-08-30 | Mitsui Toatsu Chem Inc | Cell separator and method for separating cell using the same and cell culture device and method for culturing cell using the same |
| US20040259169A1 (en) * | 2003-06-20 | 2004-12-23 | Lucina Galina-Pantoja | Methods for selection for efficient animal growth |
| US20060275841A1 (en) * | 2004-12-20 | 2006-12-07 | Martin Blankfard | Assay method and apparatus with reduced sample matrix effects |
| CN201626959U (en) * | 2010-02-01 | 2010-11-10 | 中国农业科学院北京畜牧兽医研究所 | Microperfusion Devices for Cell Culture |
| CN103305417A (en) * | 2012-03-07 | 2013-09-18 | 无锡药明康德生物技术有限公司 | High-yield reactor for protein production, and production method and application thereof |
| CN103194389A (en) * | 2013-04-16 | 2013-07-10 | 叶永清 | Device and method for in vitro high-density cultivation of erythrocyte |
Non-Patent Citations (4)
| Title |
|---|
| 卫亚红主编: "《环境生物学实验技术》", 31 May 2013 * |
| 向本琼主编: "《现代生物学实验技术指导》", 31 December 2009 * |
| 夏焕章，熊宗贵主编: "《生物技术制药》", 30 April 2006 * |
| 陈志南主编: "《细胞工程》", 31 August 2005 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111560399A (en) * | 2020-05-22 | 2020-08-21 | 苏州君盟生物医药科技有限公司 | Large-scale transient transfection method for cells |
| CN111560399B (en) * | 2020-05-22 | 2021-07-06 | 苏州君盟生物医药科技有限公司 | Mass Transient Transfection of Cells |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103320390B (en) | Large-scale mammal engineering cell cultural method | |
| CN107760651A (en) | A kind of cell culture medium and production method of protein | |
| CN102120768B (en) | Method for producing curative canine parvovirus virus monoclonal antibody by using bioreactor | |
| González‐Vara y R et al. | Enhanced production of L‐(+)‐lactic acid in chemostat by Lactobacillus casei DSM 20011 using ion‐exchange resins and cross‐flow filtration in a fully automated pilot plant controlled via NIR | |
| CN100497583C (en) | Safety high-efficient continuous enclosed type cell culture and virus production-inactivation system | |
| CN102071137B (en) | Device and method for preparing stem cells through continuous perfusion bioreactor/tank (bag) system | |
| CN102382794B (en) | Perfusion culture method of mammal cell | |
| CN103298925A (en) | Methods for culturing human myeloid leukaemia cells and cells derived therefrom | |
| CN103173507A (en) | Production technology for fermentatively producing sodium hyaluronate by utilizing bacterium | |
| CN102268402A (en) | Serum free medium and culture method for high expression of erythropoietin in CHO (Chinese hamster ovary) cells | |
| CN104845881A (en) | Apparatus and method for producing anti-CD52 monoclonal antibodies through online industrially robust regulation of cell states | |
| CN104974933B (en) | A kind of extensive continuous several times, which suspend, turns the apparatus and method of expression recombinant protein wink | |
| CN109628407A (en) | The method of high density long-term cultivation expression anti-vegf Humanized monoclonal antibodies recombinaant CHO cell | |
| CN102703374A (en) | Wall-attachment cell culture method | |
| CN102002482B (en) | Method for producing PRRS (Porcine Reproductive and Respiratory Syndrome) viruses | |
| CN109134645A (en) | A kind of cell concentration feed-batch culture technique | |
| US20240174970A1 (en) | Method for operating a bioprocess installation | |
| CN106085854A (en) | A kind of cell culture system based on hemodialyzer | |
| CN202626198U (en) | High-throughput cell culture apparatus easy for cell wall removal | |
| CN104845882A (en) | Apparatus and method for producing anti-VEGF monoclonal antibodies through online industrially robust regulation of cell states | |
| CN102886043A (en) | Binary inactivated vaccine against Japanese encephalitis virus and porcine parvovirus and preparation method thereof | |
| CN106834117A (en) | Enzyme reactor and intelligent enzyme reaction work station for releasing zooblast attaching | |
| CN104845884A (en) | Apparatus and method for producing factor VIII through online industrially robust regulation of cell states | |
| CN104845883A (en) | Apparatus and method for producing anti-Her-2 monoclonal antibodies through online industrially robust regulation of cell states | |
| CN108060130A (en) | Incubator is controlled to be suitable for the method for the induced amplification of immunocyte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150819 |